权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Polycystin Dependent Mechanisms of Tubular Plasticity

管状可塑性的多囊蛋白依赖性机制

基本信息

批准号：
10427385
负责人：
STEFAN SOMLO
金额：
$ 47.36万
依托单位：
YALE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-01 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10427385
关键词：
Address Adult Apoptotic Autosomal Dominant Polycystic Kidney Bacterial Artificial Chromosomes Biological Models Cell Culture Techniques Cell Lineage Cell Shape Cell model Cells Cilia Columnar Epithelium Complex Consensus Cre lox recombination system Cyst Cystic kidney Data Dialysis procedure Disease Enterobacteria phage P1 Cre recombinase Environment Epithelial Cells Fibrosis Gene Expression Profile Gene Silencing Genes Genetic Diseases Genetic Models Genetic Transcription Gold Hepatic Cyst Human Inflammation Inherited Intuition Kidney Kidney Diseases Laboratories Modality Modeling Molecular Monitor Morphology Mus Mutation Nephrons Orthologous Gene Outcome PKD2 protein Pathogenesis Pathway interactions Patients Phenotype Physiological Polycystic Kidney Diseases Population Process Proliferating Recovery Renal function Reproducibility Research Resolution Role Stochastic Processes Sum System Testing Therapeutic Time Tissues Transgenic Organisms Transplantation Tubular formation Validation Work base cell type field study human disease in vivo innovation kidney preservation kidney repair loss of function man molecular modeling mouse model mutant novel polycystic liver disease pre-clinical programs repaired response single-cell RNA sequencing

项目摘要

Autosomal dominant polycystic kidney disease (ADPKD) results primarily from mutations in PKD1 and PKD2 encoding polcysytin-1 (PC1) and polycystin-2 (PC2), respectively. Since PKD1 and PKD2 were discovered, there has been significant progress in understanding the functions of the polycystins (PCs). Much recent progress has been based on in vivo orthologous gene mouse models which in turn most often rely on controlled inactivation of Pkd1 or Pkd2 using the Cre-loxP system. Our past work has extended beyond Cre-loxP to include modified bacterial artificial chromosome transgenics as well as a model in which second-hit inactivation occurs by a stochastic, Cre recombinase-independent process (Pkd2WS25). While loss of function models offer valuable information, we sought to determine whether ADPKD is actually reversible following Pkd gene reactivation, and if so, at what point in the course of ADPKD is reversal still possible. We developed mouse models that use adult inducible Cre–loxP for the initial Pkd gene inactivation and a separately inducible Flp–FRT system for subsequent reactivation of the same Pkd gene to address these questions. Applying this system to Pkd2, we found that cyst formation is rapidly reversible and that dilated cysts lined by proliferating, squamoid epithelial cells rapidly revert to non-proliferating columnar epithelia with normal appearing nephron lumens, accompanied by markedly decreased total kidney volume and preservation of kidney function. We will now determine the extent to which ADPKD is reversible by extending these studies to Pkd1 inactivation/reactivation and to the Pkd2WS25 mouse which does not require Cre and develops liver cysts as well. We will determine whether there is a minimum fraction of cyst cells that need to be targeted by reactivation to reverse ADPKD and determine the latest disease stage at which ADPKD retains reversibility. We will investigate cellular and molecular alterations operational during resolution of cysts including cell lineage analyses to trace the fates of specific cell types during the repair process, assess alterations in autophagic flux following PC re-expression as a possible modality for the changes in cell shape, and determine whether inflammation and fibrosis reverse with Pkd re-expression. We will attempt to model ADPKD repair in a cell culture-based system. Finally, we will determine the dynamic changes in transcriptionally defined in vivo cell populations during polycystin re-expression and reversal of ADPKD using single cell RNA sequencing (scRNA-seq). This will define the plasticity of the cell populations and the dynamic PC2-expression-dependent changes in transcriptional profiles leading to reversion from the cystic to a more normal nephron state. The reproducible and rapid initial time course of resolution of cysts affords a unique opportunity to monitor transitions within and between cell types in near real time and define on the scale of days the changes that are controlled by PC2 re-expression in the polycystic kidney environment in vivo. All of the findings from this study will be systematically correlated internally to provide an integrated cellular and molecular model for ADPKD repair and to define the capacity and trajectory of kidney repair possible in ADPKD.

常染色体显性多囊肾病（ADPKD）主要由PKD1和PKD2突变引起